Religare Enterprises LtdQ1 FY27
Religare Enterprises Ltd Q1 FY27 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Price: ₹228P/E: 161.1Market Cap: ₹8.0K CrSector: Finance
Management growth scorecard
Revenue
Category 2
Margin
Category 3
Fundraise
Yes
Order
N/A
Capex
Yes
2 of 4 growth signals are positive.
Full analysisRevenue guidance
Category 2- →Care Health Insurance expects strong growth, with a 37% overall GWP increase in Q1 FY27 and retail new business growing over 50%.
- →Care aims to beat the industry growth rate, which is 32% for retail health, indicating continued market share gains.
- →Financial services NBFC businesses (Religare Finvest and Housing Finance) plan to grow their loan book significantly, targeting an AUM of INR10,000-15,000 crores with adequate capital (INR1,500 to 2,000 crores) earmarked for growth.
- →Broking business is in a repair and investment phase with intentions to build a new growth model; Q1 FY27 revenue increased 7% YoY with a 53% increase in PBT.
- →Overall, Religare Enterprises is focusing on increasing productivity, expanding product offerings, and tapping Tier 2 and Tier 3 markets for growth.
- →Demerger delays may slightly impact timeline but remain a focus for unlocking shareholder value.
Margin guidance
Category 3- →Care Health Insurance aims to continue market outperformance with 37% growth in GWP and retail growing 45% YoY (Page 7-8).
- →Care plans to improve combined ratio to 100% over next two years, supporting profitability (Page 9).
- →Financial Services segment (Religare Finvest) is capitalized (~INR1,500-2,000 crores) targeting INR10,000-15,000 crores AUM, indicating growth ambitions (Page 12-13).
- →Broking business is in a "repair and investment mode" with expected recovery and growth in revenue and profitability in upcoming quarters (Page 13-14).
- →Overall REL consolidated revenue grew 26% YoY, but PAT was negative this quarter due to reporting standards and investments in growth (Pages 5-6).
- →RBI regulatory approvals and structural changes like demerger could impact timing of value unlocking and profitability (Pages 8, 17-18).
- →Management is focused on operational efficiency, productivity gains, and leveraging technology platforms for sustainable earnings growth (Pages 13-14).
Track Religare Enterprises Ltd — get its next earnings analysis in your feed
Fundraise plans
Yes- →Care Health Insurance raised INR150 crores equity through rights issue in Q1 FY27 and an additional INR200 crores via subordinated debt in August 2026; the capital has already been deployed to support growth.
- →Care plans to maintain a solvency ratio around 1.7x and may raise further capital through equity or subordinated debt as needed to support solvency and growth.
- →Religare Enterprises typically subscribes fully and sometimes extra in Care’s rights issues; there is a likely upcoming rights issue planned by Care.
- →Promoters, including Religare Enterprises, have earmarked capital (around INR600 crores) for Care through rights issues and warrants conversion, with remaining INR881 crores of warrants due by March 2027.
- →No other immediate new fundraising plans mentioned; focus is on regulator approvals for demerger and value unlocking before further capital moves.
Order book
The document does not explicitly mention current or expected orderbook or pending orders for Religare Enterprises Limited. However, relevant financial service and business update details that indirectly relate to business growth and plans include:
- The NBFC and HFC businesses are capitalized with ambitions for a loan book size of INR10,000 crores to INR15,000 crores.
- NBFC capital is about INR1,000 crores, HFC around INR200 crores, with INR250 crores planned topping up.
- Focus on business growth and value unlocking subject to RBI approvals.
- Broking business saw a rebound with revenue growth and increased client debit book by 78% YoY.
- CARE Health Insurance raised equity and sub-debt capital to support expansion.
- Legacy loan book recovery efforts underway with a written-off pool of INR350-400 crores within next two years.
No direct orderbook or pending order details are provided in the available transcript.
Capex plans
Yes- →Care Health Insurance raised INR150 crores equity through rights issue in Q1 FY27 and INR200 crores sub-debt in August 2026 to support business growth as per IRDAI norms.
- →Additional capital infusion planned to maintain solvency ratio at 1.7x; promoters, including Religare Enterprises Limited (REL) and Kedaara, committed to funding as needed.
- →REL subscribed fully and beyond its quota in rights issues, marginally increasing its stake in Care.
- →Care aims to deploy raised capital primarily for business growth and profitability enhancement.
- →Financial services business (NBFC and HFC) is sufficiently capitalized with about INR1,500-2,000 crores of capital earmarked, targeting a book size of INR10,000-15,000 crores.
- →No current plans for demerger; engaging with regulators before considering value unlocking strategies.
- →No specific new capex projects disclosed; focus remains on capitalizing existing businesses and growth initiatives.
How does Religare Enterprises Ltd rank vs peers in Finance?
Pro feature1Religare Enterprises Ltd
Rev 2Mar 3
See full Finance sector rankings
How does Religare Enterprises Ltd rank in Finance?
Compare Religare Enterprises Ltd against every Finance company (Q1 FY27) on revenue, margins and earnings-call signals.